E
FUSN

Ergoteles’s Fusion Pharmaceuticals Inc. Common Shares FUSN Stock Holding History

Ergoteles’s Portfolio FUSN Stock Details FUSN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-11,000
Closed -$46K – 1713
2021
Q4 		$46K Buy
+11,000
New +$68.6K ﹤0.01% 1183

Other funds holding FUSN

JJ
Johnson & Johnson New Brunswick, New Jersey $652M AUM 198.07% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Canada Pension Plan Investment Board
Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $155B AUM 29.93% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
ASP
Adams Street Partners Chicago, Illinois $260M AUM 30.38% 1-Year Est. Return
TGA
TPG GP A Fort Worth, Texas $3.68B AUM 14.99% 1-Year Est. Return
PBPIA
Pivotal bioVenture Partners Investment Advisor San Francisco, California $280M AUM 181.4% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

Ergoteles's FUSN Position: Q1 2022 in Review

Ergoteles sold out of Fusion Pharmaceuticals Inc. Common Shares (FUSN) in Q1 2022, closing a stake of 11,000 shares — an estimated $46K sold.

Ergoteles first reported a position in FUSN in Q4 2021 and held it in 1 quarter. The position peaked at $46K in Q4 2021. 28 funds tracked by Wall St. Rank hold FUSN as of Q1 2022.

  • Ergoteles reported no remaining Fusion Pharmaceuticals Inc. Common Shares position as of Q1 2022 after selling out during the quarter.
  • Ergoteles sold 11,000 Fusion Pharmaceuticals Inc. Common Shares shares in Q1 2022, an estimated $46K.
  • Ergoteles first reported a position in Fusion Pharmaceuticals Inc. Common Shares in Q4 2021 and held it in 1 quarter.
  • Ergoteles's Fusion Pharmaceuticals Inc. Common Shares position peaked at $46K in Q4 2021.
  • 28 funds tracked by Wall St. Rank held Fusion Pharmaceuticals Inc. Common Shares as of Q1 2022.

Based on Ergoteles's 13F filing for Q1 2022, filed 13 May 2022.